Literature DB >> 12744880

Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?

S C Clarke1, M A Diggle, P Mölling, M Unemo, P Olcén.   

Abstract

Outer membrane protein (OMP) vaccines are being developed against Neisseria meningitidis serogroup B which may provide protection against common circulating serotypes and serosubtypes in some countries. However, limited data is available in Europe from genosubtyping meningococci. We therefore undertook a retrospective analysis of the three main variable regions, VR1, VR2 as well as VR3, of the porA gene from N. meningitidis isolated from different countries, mainly from Scotland and Sweden. Analysis of this gene showed that, amongst 226 strains studied, there were a total of 78 different strains. No new VR1 or VR2 alleles were found but five new VR3 alleles are described. Our data indicates the importance of analysing the VR3 region of PorA in addition to VR1 and VR2 and also highlights, in general terms, the need for genosubtyping meningococci. Such analyses have major implications for the design of new meningococcal vaccines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12744880     DOI: 10.1016/s0264-410x(03)00033-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

Review 1.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 2.  Genotypic characterization of Neisseria meningitidis using Pyrosequencing.

Authors:  Matthew A Diggle; Stuart C Clarke
Journal:  Mol Biotechnol       Date:  2004-10       Impact factor: 2.695

Review 3.  Multilocus sequence typing: Data analysis in clinical microbiology and public health.

Authors:  Christopher B Sullivan; Matthew A Diggle; Stuart C Clarke
Journal:  Mol Biotechnol       Date:  2005-03       Impact factor: 2.695

4.  PorA variable antigenic regions VR1, VR2, and VR3 of Neisseria meningitidis serogroups B and C isolated in Brazil from 1999 to 2004.

Authors:  Ivano de Filippis; Claudia Ferreira de Andrade; Luciete Silva; D Rebecca Prevots; Ana Carolina P Vicente
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

5.  Functional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines.

Authors:  E Wedege; K Bolstad; A Aase; T K Herstad; L McCallum; E Rosenqvist; P Oster; D Martin
Journal:  Clin Vaccine Immunol       Date:  2007-05-09

6.  Evidence for capsule switching between carried and disease-causing Neisseria meningitidis strains.

Authors:  Amanda J Beddek; Ming-Shi Li; J Simon Kroll; T William Jordan; Diana R Martin
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

7.  Genetic characteristics of Neisseria meningitidis serogroup B strains carried by adolescents living in Milan, Italy: implications for vaccine efficacy.

Authors:  Susanna Esposito; Alberto Zampiero; Leonardo Terranova; Valentina Montinaro; Alessia Scala; Valentina Ansuini; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2013-07-23       Impact factor: 3.452

8.  Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.

Authors:  Roberto Gasparini; Maurizio Comanducci; Daniela Amicizia; Filippo Ansaldi; Paola Canepa; Andrea Orsi; Giancarlo Icardi; Emanuela Rizzitelli; Gabriella De Angelis; Stefania Bambini; Monica Moschioni; Sara Comandi; Isabella Simmini; Giueseppe Boccadifuoco; Brunella Brunelli; Marzia Monica Giuliani; Mariagrazia Pizza; Donatella Panatto
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

9.  Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003.

Authors:  Jianwei Zhou; Brigitte Lefebvre; Saul Deng; Rodica Gilca; Genevieve Deceuninck; Dennis K S Law; Philippe De Wals; Raymond S W Tsang
Journal:  J Clin Microbiol       Date:  2012-02-15       Impact factor: 5.948

10.  Characterization of serogroup A Neisseria meningitidis from invasive meningococcal disease cases in Canada between 1979 and 2006: Epidemiological links to returning travellers.

Authors:  Angela M Sloan; Averil M Henderson; Raymond Sw Tsang
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-05       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.